Akums Drugs & Pharmaceuticals Ltd. (AKUMS): Akums Drugs & Pharmaceuticals Share Price near 52-week high after 2.72% rise

Akums Share Price traded at Rs 787, up 2.72% from the previous close of Rs 766.15, as the stock stayed close to its 52-week high and carried a market capitalisation of Rs 12,148.45 crore. The move places Akums Drugs & Pharmaceuticals Ltd. (AKUMS) firmly in today’s stock news flow, with the latest Univest data confirming a near yearly high event rather than a new peak. The price action matters because it gives a fresh read on Akums Share Price Today, while the company’s valuation and sector positioning add context for readers tracking Akums Stock News and Akums Share News.

As of 18 September 2026 at 2:48 PM IST, Akums traded between Rs 772.25 and Rs 789.75 after opening at Rs 772.4. The stock’s Rs 20.85 rise reflected a 2.72% move, and turnover stood at Rs 0.46 crore. The latest Univest figures confirm that the stock is trading near its 52-week high, which makes Akums Share Price a closely watched name in the Indian stock market today.

Akums Share Price Today: Price Action Analysis

Metric	Value
Current Price	Rs 787
Previous Close	Rs 766.15
Today's Move	+Rs 20.85 (+2.72%)
Open	Rs 772.4
High	Rs 789.75
Low	Rs 772.25
Turnover	Rs 0.46 crore
Market Capitalisation	Rs 12,148.45 crore

Akums Drugs & Pharmaceuticals Ltd. (AKUMS) traded at Rs 787 versus the previous close of Rs 766.15, a rise of 2.72%. The stock opened at Rs 772.4, reached a high of Rs 789.75 and touched a low of Rs 772.25.

Akums Share Price Today reflects a clear intraday move above the previous close, with the stock last traded at Rs 787 versus Rs 766.15 earlier. The opening price of Rs 772.4 was followed by a day’s low of Rs 772.25 and a day’s high of Rs 789.75, placing the stock close to its session high at the time of writing. Turnover of Rs 0.46 crore gives a factual read on traded value, while the near-52-week-high screen shows that this remains an event-led stock update for market watchers scanning Stocks in News and 52 Week High Stocks.

What exactly happened today is straightforward: Akums moved higher on the day and traded near its one-year high without the article assigning any company-specific trigger. The latest Univest data confirms the price event, but it does not establish a separate catalyst. For readers comparing Akums Share Price Live with broader Share Market Today action, the key point is that the stock stayed within range of its yearly peak while finishing this price leg at Rs 787.

Akums Drugs & Pharmaceuticals Ltd. (AKUMS) Fundamental Analysis

Metric	Value
Market Capitalisation	Rs 12,148.45 crore
P/E Ratio	41.34x
P/B Ratio	3.53x
ROE	8.06%
ROCE	14.77%
EPS	Rs 18.53
Book Value Per Share	Rs 216.98
Dividend Yield	0.39%

Akums Drugs & Pharmaceuticals Ltd. (AKUMS) fundamental metrics show P/E 41.34x, P/B 3.53x, ROE 8.06%, ROCE 14.77%. These figures provide context only and are not a buy or sell signal.

Akums Drugs & Pharmaceuticals Ltd. has a market capitalisation of Rs 12148.45 crore, which gives readers a sense of company size before judging valuation. On valuation, P/E at 41.34x, P/B at 3.53x should be read against the sector and peer benchmarks rather than as a standalone signal. Profitability is represented by ROE of 8.06% and ROCE of 14.77%, helping investors compare shareholder returns and capital efficiency. According to latest Univest data, additional metrics include EPS of Rs 18.53, book value per share of Rs 216.98, dividend yield of 0.39%, adding context to earnings, balance-sheet value and historical payout. Against the latest Univest same industry benchmark, these figures can be compared with benchmark median P/E of 28.19x, median ROE of 11.78%, median ROCE of 13.61%. These numbers explain the fundamental backdrop without converting the article into a buy or sell view.

Sector and Industry Context

Metric	Value
Sector	Healthcare
Industry	Pharmaceuticals & Drugs
Benchmark Scope	same industry
Company P/E Ratio	41.34x
Benchmark Median P/E	28.19x
Benchmark Average P/E	37.54x
Benchmark P/E Range	0x to 417.17x
Company P/B Ratio	3.53x
Benchmark Median P/B	3.08x
Company ROE	8.06%
Benchmark Median ROE	11.78%
Company ROCE	14.77%
Benchmark Median ROCE	13.61%
Company Market Capitalisation	Rs 12,148.45 crore
Benchmark Median Market Cap	Rs 733.35 crore

Akums Drugs & Pharmaceuticals Ltd. (AKUMS) is classified under sector: Healthcare and industry: Pharmaceuticals & Drugs.

Akums Drugs & Pharmaceuticals Ltd. (AKUMS) has a P/E ratio of 41.34x, which is above the benchmark median of 28.19x, a difference of +46.65%. P/E is a valuation multiple and is not, by itself, a buy or sell signal.

Akums Drugs & Pharmaceuticals Ltd. (AKUMS) has a ROE of 8.06%, which is below the benchmark median of 11.78%, a difference of -31.58%. Akums Drugs & Pharmaceuticals Ltd. (AKUMS) has a ROCE of 14.77%, which is above the benchmark median of 13.61%, a difference of +8.52%.

Track stocks reaching yearly peaks through the Univest 52-week-high screener. The peer table below provides the company-level comparison.

Peer Comparison

Company	Symbol	Market Cap (Cr)	P/E	P/B	ROE (%)	ROCE (%)
Sudeep Pharma Ltd.	SUDEEPPHRM	12,515.84	68.41	13.52	25.37	28.5
CORONA Remedies Ltd.	CORONA	13,129.85	66.48	16.4	27.36	31.74
Strides Pharma Science Ltd.	STAR	10,955.19	18.03	3.38	20.31	18.57
Blue Jet Healthcare Ltd.	BLUEJET	10,676.1	45.88	4.82	19.88	27.18
Sequent Scientific Ltd.	VIYASH	10,521.83	63.01	3.83	9.06	13.1

Akums Drugs & Pharmaceuticals Ltd. (AKUMS) has a P/E ratio of 41.34x compared with the displayed peer median of 63.01x. This is a relative valuation comparison, not a buy or sell signal. Its ROE of 8.06% compares with a peer median of 20.31% across the companies shown in the table. ROCE stood at 14.77% versus the displayed peer median of 27.18%, providing a capital-efficiency comparison. Akums Drugs & Pharmaceuticals Ltd. (AKUMS) has a market capitalisation of Rs 12,148.45 crore. Among the 5 peers shown, 2 have a larger market capitalisation.

Why Investors Are Watching Akums

• Akums Share Price traded at Rs 787, up 2.72% from the previous close of Rs 766.15.
• The stock stayed near its 52-week high and one-year high during the latest price update.
• Market capitalisation stood at Rs 12,148.45 crore in the latest Univest figures.
• P/E of 41.34 is above the same-industry median of 28.19 and average of 37.54.
• ROCE of 14.77% is above the industry median of 13.61%, while ROE of 8.06% is below the median of 11.78%.

About Akums

Akums Drugs & Pharmaceuticals Ltd. operates in the Healthcare sector and the Pharmaceuticals & Drugs industry. The company is tracked on NSE and BSE as AKUMS. For readers researching Akums Share Price, this classification is useful because it places the stock inside a defined peer set and sector benchmark. Akums Share Price Today therefore sits within a clear industry context that also includes valuation, earnings, and return ratios from the latest Univest figures.

Frequently Asked Questions

Why is Akums Share Price in the news today?

Ans. Akums Share Price is in focus because it traded at Rs 787, up 2.72% from the previous close, while staying close to its 52-week high. The move also keeps Akums Stock News on market watchlists.

What is Akums Share Price today?

Ans. Akums Share Price today is Rs 787. The stock moved above the previous close of Rs 766.15 and traded near its one-year high, which is why Akums Share Price Today is drawing attention.

How far is Akums Share Price from its 52-week high?

Ans. Akums Share Price traded at Rs 787, while the day’s high was Rs 789.75. The latest Univest data shows the stock staying close to its 52-week high rather than setting a new peak.

What does Akums market capitalisation stand at?

Ans. Akums market capitalisation stands at Rs 12,148.45 crore. That places Akums Share Price above the same-industry median market cap and below the average, giving useful context for Akums Stock Analysis.

How are Akums valuation ratios positioned?

Ans. Akums Share Price has a P/E of 41.34 and a P/B of 3.53. Both sit above the industry median, which means the valuation is higher than the benchmark central levels used in the sector comparison.

What do Akums profitability ratios show?

Ans. Akums reports ROE of 8.06% and ROCE of 14.77%. ROE is below the industry median, while ROCE is above it, so Akums Fundamental Analysis shows mixed return ratios rather than a single direction.

What earnings metrics are available for Akums?

Ans. Akums Share Price is supported by EPS of Rs 18.53 and book value of Rs 216.98. Dividend yield is 0.39%, which gives readers a factual earnings, asset and payout context for Akums Financial Results.

Which sector and industry does Akums belong to?

Ans. Akums belongs to the Healthcare sector and the Pharmaceuticals & Drugs industry. That classification is important for Akums Share Price because it allows comparison with peers, sector medians and broader Akums Latest News.

Track Akums Share Price on Univest

Use Akums Drugs & Pharmaceuticals Ltd. (AKUMS) live share-price page, Univest 52-week-high screener, Univest market blogs to review live stock data, yearly-high lists and related market analysis.

You can track Akums Share Price on Univest for live price updates, share price today movement, 52-week high levels, fundamental ratios, share price news and broader market insights. Univest also helps readers follow Akums Stock News, Akums Share Price Live and Akums Stock Analysis in one place.